Clinical Trial Update: Safety and Pharmacokinetics Study of amlodipine10mg and candesartan32mg [Phase 1]

View source ↗

Summary

Phase 1 safety and pharmacokinetics study of fixed-dose amlodipine 10 mg and candesartan 32 mg completed for hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Amlodipine (amlodipine)
• Candesartan (candesartan)

Snippet

Sponsor: HanAll BioPharma Co., Ltd. | Conditions: Hypertension | Phase 1 | Status: COMPLETED